期刊文献+

国产多西他赛联合表阿霉素治疗晚期乳腺癌36例临床分析 被引量:5

下载PDF
导出
摘要 目的观察多西他赛联合表阿霉素治疗晚期乳腺癌的疗效及其毒副作用。方法应用多西他赛联合表阿霉素治疗晚期乳腺癌36例,其中初始治疗者30例,复发或出现转移再治疗者6例。按21d为一个周期,行4~6个周期化疗后对患者的症状,瘤体大小及毒副作用进行总结评价。结果 36例患者中,5例完全缓解,19例部分缓解,4例处于病情稳定,8例病情出现进展。临床有效率66.7%,临床获益率达77.8%。毒副反应主要以胃肠道反应和骨髓抑制为主,多为Ⅰ~Ⅱ度。结论国产多西他赛联合表阿霉素治疗晚期乳腺癌有较好的疗效,而且毒副反应轻,可作为晚期乳腺癌的首选化疗方案。
作者 田迎霞
出处 《中国实用医药》 2011年第9期148-149,共2页 China Practical Medicine
  • 相关文献

参考文献5

二级参考文献65

  • 1姜丽娜,于世英,熊慧华,张孟贤.胸苷磷酸化酶在癌组织中表达的研究[J].中华肿瘤杂志,2004,26(5):297-299. 被引量:72
  • 2江泽飞,宋三泰,徐建明,刘晓晴,李彦博,赵平瑜.单用去甲长春花碱治疗复发转移乳癌[J].中华肿瘤杂志,1996,18(3):208-210. 被引量:45
  • 3[4]Ray-Coquard I, Biron P, Bachelot T, et al. Vinorelbine and cisplatin (CICIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline-and (or) paclitaxel-containing regimens. Cancer, 1998, 82:134
  • 4Ibrahim NK, Rahman Z, Valero V, et al. Phase Ⅰ study of vinorelbine and docetaxel with granulocyte colony-stimulating factor support in the treatment of metastatic breast cancer [J]. Cancer Invest, 2002,20(1): 29-37.
  • 5Venturini M, Del Mastro L, Garrone O, et al. Phase Ⅰ, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer [ J ]. Ann Oncol, 2002,13(4): 546-552.
  • 6Schwetz BA. From the Food and Drug Administration [J]. JAMA,2001,286(17) : 2085.
  • 7O'Shaughnessy J, Miles D, Vukelja S, et al. Superior survival with capecitabine plus docetaxel combination therapy in anthracyclin-pretreated patients with advanced breast cancer: phase Ⅲ trial results [J]. J Clin Oncol, 2002,20(12): 2812-2823.
  • 8Brugnatelli S, Danova M, De Bella MT, et al. Weekly administration of gemcitabine plus docetaxel in patients with advanced breast cancer: a phase 1 study [J]. Oncology, 2002,62(1): 33-38.
  • 9Frasci G, Comella P, D' Aiuto G, et al. Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: a parallel dose-finding study [J]. Ann Oncol, 2000, 11(3):367-371.
  • 10Burris HA 3rd.Docetaxel (Taxotere) plus trasuzumab (Herceptin) in breast cancer [J]. Semin Oncol, 2001,28(1 Suppl 3) : 38-44.

共引文献166

同被引文献26

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部